Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model.

Tytuł:
Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model.
Autorzy:
Rawls KD; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Dougherty BV; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Vinnakota KC; Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD 21702, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), Bethesda, MD 20817, USA.
Pannala VR; Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD 21702, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), Bethesda, MD 20817, USA.
Wallqvist A; Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Development Command, Fort Detrick, MD 21702, USA.
Kolling GL; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA; Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908, USA.
Papin JA; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA; Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908, USA; Department of Biochemistry & Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA. Electronic address: .
Źródło:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2021 Feb 01; Vol. 412, pp. 115390. Date of Electronic Publication: 2020 Dec 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Język:
English
Imprint Name(s):
Publication: New York, NY : Academic Press
Original Publication: New York.
MeSH Terms:
Energy Metabolism/*drug effects
Epithelial Cells/*drug effects
Kidney Diseases/*chemically induced
Kidney Tubules, Proximal/*drug effects
Metabolome/*drug effects
Transcriptome/*drug effects
Acetaminophen/toxicity ; Animals ; Cells, Cultured ; Databases, Genetic ; Energy Metabolism/genetics ; Epithelial Cells/metabolism ; Epithelial Cells/pathology ; Female ; Gene Expression Profiling ; Gene Regulatory Networks ; Gentamicins/toxicity ; Kidney Diseases/genetics ; Kidney Diseases/metabolism ; Kidney Diseases/pathology ; Kidney Tubules, Proximal/metabolism ; Kidney Tubules, Proximal/pathology ; Metabolome/genetics ; Metabolomics ; Polychlorinated Dibenzodioxins/toxicity ; Rats, Sprague-Dawley ; Trichloroethylene/toxicity
References:
Mar Drugs. 2017 May 09;15(5):. (PMID: 28486425)
Mamm Genome. 2016 Apr;27(3-4):158-67. (PMID: 26923795)
Mol Syst Biol. 2011 Oct 11;7:535. (PMID: 21988831)
Compr Physiol. 2013 Jul;3(3):1191-212. (PMID: 23897684)
Kidney Int. 1986 Jan;29(1):54-67. (PMID: 3515015)
Kidney Int. 2011 May;79(10):1119-30. (PMID: 21307838)
J Toxicol Sci. 2008 Feb;33(1):85-96. (PMID: 18303187)
J Med Toxicol. 2008 Mar;4(1):2-6. (PMID: 18338302)
Nat Protoc. 2011 Aug 04;6(9):1290-307. (PMID: 21886097)
J Pharmacol Exp Ther. 2001 Apr;297(1):155-64. (PMID: 11259540)
J Biol Chem. 2006 Jun 16;281(24):16768-76. (PMID: 16608839)
Fundam Appl Toxicol. 1988 Jul;11(1):132-42. (PMID: 2905310)
Mol Syst Biol. 2014 Mar 19;10:721. (PMID: 24646661)
Adv Clin Chem. 2015;68:57-69. (PMID: 25858868)
Arch Biochem Biophys. 1980 Nov;205(1):222-31. (PMID: 7447479)
J Cell Biol. 2015 Apr 27;209(2):199-210. (PMID: 25918223)
Nat Commun. 2014;5:3083. (PMID: 24419221)
Nat Biotechnol. 2010 May;28(5):478-85. (PMID: 20458318)
Toxicology. 1989 Apr;55(1-2):131-41. (PMID: 2711399)
J Lipid Res. 2008 May;49(5):1137-46. (PMID: 18281723)
Comput Biol Med. 2019 Feb;105:64-71. (PMID: 30584952)
PLoS One. 2014 Aug 15;9(8):e105383. (PMID: 25127241)
Nucleic Acids Res. 2002 Jan 1;30(1):207-10. (PMID: 11752295)
J Am Soc Nephrol. 2009 Mar;20(3):672-9. (PMID: 19244578)
Life Sci. 2008 Feb 27;82(9-10):450-9. (PMID: 18201728)
OMICS. 2012 May;16(5):284-7. (PMID: 22455463)
Biochem Pharmacol. 2010 Feb 1;79(3):487-97. (PMID: 19782052)
Ther Drug Monit. 2019 Apr;41(2):213-226. (PMID: 30883514)
Methods Mol Biol. 2017;1609:149-170. (PMID: 28660581)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
Nat Biotechnol. 2016 May;34(5):525-7. (PMID: 27043002)
Metabolomics. 2016;12:109. (PMID: 27358602)
Nat Biotechnol. 2010 May;28(5):463-9. (PMID: 20458316)
Toxicol Sci. 2019 Dec 1;172(2):279-291. (PMID: 31501904)
Front Pharmacol. 2018 Sep 25;9:939. (PMID: 30319399)
Trans Am Clin Climatol Assoc. 2014;125:293-9; discussion 299. (PMID: 25125746)
Curr Protoc Mol Biol. 2016 Apr 01;114:30.4.1-30.4.32. (PMID: 27038389)
Res Commun Chem Pathol Pharmacol. 1980 Mar;27(3):521-31. (PMID: 7384641)
Am J Physiol. 1986 Nov;251(5 Pt 2):F765-76. (PMID: 3022602)
Wiley Interdiscip Rev Syst Biol Med. 2013 Sep-Oct;5(5):557-73. (PMID: 23852667)
Annu Rev Pharmacol Toxicol. 2008;48:463-93. (PMID: 17937594)
Am J Physiol. 1988 Sep;255(3 Pt 2):F397-407. (PMID: 3414800)
Toxicol Appl Pharmacol. 1989 Oct;101(1):144-57. (PMID: 2799813)
Biomed Res Int. 2013;2013:187509. (PMID: 24222897)
Physiol Res. 2016 Nov 8;65(4):627-635. (PMID: 26988152)
Kidney Int. 2007 May;71(10):971-6. (PMID: 17396117)
Nat Biotechnol. 2013 May;31(5):419-25. (PMID: 23455439)
Kidney Int. 1982 Apr;21(4):539-45. (PMID: 7047859)
Eur Cytokine Netw. 2013 Jun;24(2):91-6. (PMID: 23823010)
F1000Res. 2015 Dec 30;4:1521. (PMID: 26925227)
BMC Genomics. 2017 Jul 19;18(1):543. (PMID: 28724354)
Math Biosci. 2015 Jun;264:8-20. (PMID: 25765886)
Toxicol Appl Pharmacol. 2019 Jun 1;372:19-32. (PMID: 30974156)
Toxicology. 2004 Nov 15;204(2-3):187-95. (PMID: 15388244)
Mol Biosyst. 2010 May;6(5):909-21. (PMID: 20567778)
Curr Opin Nephrol Hypertens. 2010 Jul;19(4):393-402. (PMID: 20489613)
Kidney Blood Press Res. 2016;41(6):911-918. (PMID: 27889773)
Biochem J. 1969 Apr;112(2):149-66. (PMID: 5805283)
Acta Med Indones. 2012 Jul;44(3):246-55. (PMID: 22983082)
Toxicol Sci. 2006 Dec;94(2):398-416. (PMID: 16960034)
N Am J Med Sci. 2010 Apr;2(4):170-3. (PMID: 22624135)
Toxicol Appl Pharmacol. 1983 Jun 30;69(2):291-306. (PMID: 6868091)
Toxicol Appl Pharmacol. 2011 Apr 15;252(2):112-22. (PMID: 21081137)
Ren Physiol Biochem. 1993 Nov-Dec;16(6):311-24. (PMID: 7506440)
Am J Physiol Cell Physiol. 2006 Dec;291(6):C1129-47. (PMID: 16760263)
BMC Bioinformatics. 2011 Jun 22;12:254. (PMID: 21696593)
Biomol Ther (Seoul). 2012 May;20(3):268-72. (PMID: 24130922)
Clin Kidney J. 2012 Apr;5(2):102-108. (PMID: 22833807)
Toxicol Lett. 1997 Sep 19;93(1):15-22. (PMID: 9381478)
Am J Physiol Renal Physiol. 2014 Apr 1;306(7):F724-33. (PMID: 24477687)
PLoS Comput Biol. 2010 Sep 23;6(9):e1000938. (PMID: 20957118)
Cell. 2015 May 21;161(5):971-987. (PMID: 26000478)
Nat Commun. 2017 Mar 07;8:14631. (PMID: 28266498)
Antioxid Redox Signal. 2016 Jul 20;25(3):119-46. (PMID: 26906267)
Am J Clin Nutr. 2004 Feb;79(2):185-97. (PMID: 14749222)
J Clin Invest. 1969 Mar;48(3):574-83. (PMID: 5773093)
Lancet. 2012 Aug 25;380(9843):756-66. (PMID: 22617274)
Metabolomics. 2015 Jun 1;11(3):707-721. (PMID: 26190955)
Diabetes Care. 2001 Feb;24(2):382-91. (PMID: 11213896)
Pharm Biol. 2016 Oct;54(10):2082-91. (PMID: 26956915)
Nat Commun. 2017 Feb 08;8:14250. (PMID: 28176778)
Am J Clin Nutr. 2006 May;83(5):1062-7. (PMID: 16685047)
Sci Rep. 2018 Jan 9;8(1):156. (PMID: 29317676)
Aging Cell. 2015 Dec;14(6):933-44. (PMID: 26331998)
Grant Information:
T32 GM008715 United States GM NIGMS NIH HHS
Contributed Indexing:
Keywords: Kidney; Kidney Metabolism; Metabolic Modeling; Metabolomics; Nephrotoxicity; Transcriptomics
Substance Nomenclature:
0 (Gentamicins)
0 (Polychlorinated Dibenzodioxins)
290YE8AR51 (Trichloroethylene)
362O9ITL9D (Acetaminophen)
Entry Date(s):
Date Created: 20210102 Date Completed: 20210511 Latest Revision: 20220202
Update Code:
20240105
PubMed Central ID:
PMC7859602
DOI:
10.1016/j.taap.2020.115390
PMID:
33387578
Czasopismo naukowe
The kidneys are metabolically active organs with importance in several physiological tasks such as the secretion of soluble wastes into the urine and synthesizing glucose and oxidizing fatty acids for energy in fasting (non-fed) conditions. Once damaged, the metabolic capability of the kidneys becomes altered. Here, we define metabolic tasks in a computational modeling framework to capture kidney function in an update to the iRno network reconstruction of rat metabolism using literature-based evidence. To demonstrate the utility of iRno for predicting kidney function, we exposed primary rat renal proximal tubule epithelial cells to four compounds with varying levels of nephrotoxicity (acetaminophen, gentamicin, 2,3,7,8-tetrachlorodibenzodioxin, and trichloroethylene) for six and twenty-four hours, and collected transcriptomics and metabolomics data to measure the metabolic effects of compound exposure. For the transcriptomics data, we observed changes in fatty acid metabolism and amino acid metabolism, as well as changes in existing markers of kidney function such as Clu (clusterin). The iRno metabolic network reconstruction was used to predict alterations in these same pathways after integrating transcriptomics data and was able to distinguish between select compound-specific effects on the proximal tubule epithelial cells. Genome-scale metabolic network reconstructions with coupled omics data can be used to predict changes in metabolism as a step towards identifying novel metabolic biomarkers of kidney function and dysfunction.
(Copyright © 2021 Elsevier Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies